Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
33 results
D1.64 - Distinct and Overlapping Sensitization Patterns to Crustacean and House Dust Mite Allergens in Tropical Allergy
D1.72 - Assessing potential influencing factors on allergic reaction to the cumulative dose given on an extra day within oral food challenge in food-allergic children
D1.75 - Association of SCORAD Values with Skin Barrier Function Indicators in Patients with Atopic Dermatitis
D1.61 - Shrimp Tropomyosin as a Selective Allergen in a Case of Food Allergy: The Value of Individualized Molecular Analysis
D1.62 - Thermal stress alters the allergen and proteome profile of the redclaw crayfish (Cherax quadicarinatus)
D1.63 - Suspected Hypersensitivity to Non-Nutritive Sweeteners With Recurrent Respiratory Manifestations in a Pediatric Patient
D1.65 - Selective Allergy to Large Prawn: Identification of a Projectin-Derived IgE-Binding Protein
D1.66 - Allergy profiling in selective goat and sheep milk allergy
D1.67 - Comparison of machine learning models for grass carp allergy diagnosis
D1.70 - IgE-sensitization to allergens in plant-based drinks in children with cow’s milk allergy
D1.71 - Can an allergist predict the development of allergies? A Clinical case of dizygotic twins with divergent outcomes
D1.73 - Date Palm or Grass pollen rhinoconjuctivitis in a patient with watermelon allergy?
D1.74 - Sunflower Seed–Induced Anaphylaxis: Allergenic Characterization and Evidence of Cross-Reactivity with Niger Seeds
D3.418 - A Phase 1b Study of Lesigercept, a Long-acting High-affinity IgETrap-Fc Fusion Protein: Safety, Tolerability, PK, and PD in Atopic Healthy and Allergic Subjects
D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset
D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study
D3.421 - Real-world Effectiveness and Safety of Lanadelumab Treatment in Patients With Hereditary Angioedema: The 12-Month Interim Analysis of a Polish, Prospective, Multicenter, Observational Study (CHOPIN)
D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes
D3.423 - Lanadelumab treatment is effective and safe in patients with Factor XII associated cold-induced autoinflammatory syndrome: results from an open-label proof-of-concept study
D3.424 - Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download